BaseFortify

Publication date: 2026-01-20

Last updated on: 2026-01-29

Assigner: Oracle

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

CVSS Scores

EPSS Scores

Probability:
Percentile:

Meta Information

Published

2026-01-20

Last Modified

2026-01-29

Generated

2026-07-06

AI Q&A

2026-01-21

EPSS Evaluated

2026-07-05

NVD

CVE-2026-21974

EUVD

EUVD-2026-3538

Affected Vendors & Products

Vendor	Product	Version / Range
oracle	life_sciences_central_designer	7.0.1.0

Helpful Resources

Exploitability

CWE

KEV

CWE ID	Description
CWE-200	The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.

Attack-Flow Graph

Executive Summary

This vulnerability exists in the Oracle Life Sciences Central Designer product, version 7.0.1.0. It allows an unauthenticated attacker with network access via HTTP to exploit the system easily and gain unauthorized read access to some of the data accessible through Oracle Life Sciences Central Designer.

Impact Analysis

The impact of this vulnerability is unauthorized disclosure of some data within Oracle Life Sciences Central Designer. An attacker could read sensitive information without authentication, potentially leading to data exposure.

Hi! I’m here to help you understand CVE-2026-21974. Ask me anything about the vulnerability, its impact, or mitigation strategies.

0/70